Literature DB >> 17513515

Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus.

Vinod Pullarkat1, Leslie Veliz, Karen Chang, Ann Mohrbacher, Anna Lizza Teotico, Stephen J Forman, Marilyn L Slovak.   

Abstract

Myeloid sarcomas are tumour masses of myeloid leukaemic cells at extramedullary sites. These tumours can, on occasion, occur without concurrent or antecedent leukaemia. Myeloid sarcomas have been described at unusual locations including the female genital tract. An unusual case of therapy-related acute myeloid leukaemia (t-AML) presenting as isolated monoblastic myeloid sarcoma of the uterus in a patient who had received adjuvant chemotherapy for breast cancer is presented. Fluorescence in situ hybridisation analysis performed on paraffin-wax-embedded tumour tissue revealed a mixed-lineage leukaemia (MLL) gene rearrangement, supporting the association of this malignancy with prior chemotherapy. This case illustrates that t-AML can rarely present as isolated extramedullary tumours, and the detection of specific chromosomal abnormalities in these myeloid sarcomas can be useful for risk assessment and guiding definitive therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17513515      PMCID: PMC1994540          DOI: 10.1136/jcp.2005.033266

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.

Authors:  C C Chang; C Eshoa; B Kampalath; V B Shidham; S Perkins
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

Review 2.  Therapy related leukemias: susceptibility, prevention and treatment.

Authors:  G Leone; M T Voso; S Sica; R Morosetti; L Pagano
Journal:  Leuk Lymphoma       Date:  2001-04

Review 3.  New insight into the molecular mechanisms of MLL-associated leukemia.

Authors:  Z-Y Li; D-P Liu; C-C Liang
Journal:  Leukemia       Date:  2005-02       Impact factor: 11.528

4.  Acute obstructive renal failure secondary to granulocytic sarcoma (chloroma).

Authors:  G S Steinbock; P M Morrisseau; R K Vinson
Journal:  Urology       Date:  1986-03       Impact factor: 2.649

Review 5.  Granulocytic sarcoma of the uterine cervix--literature review of granulocytic sarcoma of the female genital tract.

Authors:  H D Friedman; M D Adelson; R C Elder; S M Lemke
Journal:  Gynecol Oncol       Date:  1992-07       Impact factor: 5.482

6.  Primary myeloid sarcoma of the gynecologic tract: a report of two cases progressing to acute myeloid leukemia.

Authors:  José-Angel Hernández; José-Tomás Navarro; María Rozman; Josep-María Ribera; Montserrat Rovira; María-Alba Bosch; María-José Fantova; José-Luis Mate; Fuensanta Millá
Journal:  Leuk Lymphoma       Date:  2002-11

7.  Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification.

Authors:  L Quintanilla-Martínez; L R Zukerberg; J A Ferry; N L Harris
Journal:  Am J Clin Pathol       Date:  1995-10       Impact factor: 2.493

8.  A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization.

Authors:  Sarah F Paternoster; Stephanie R Brockman; Rebecca F McClure; Ellen D Remstein; Paul J Kurtin; Gordon W Dewald
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.

Authors:  H J Super; N R McCabe; M J Thirman; R A Larson; M M Le Beau; J Pedersen-Bjergaard; P Philip; M O Diaz; J D Rowley
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

Review 10.  Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis.

Authors:  J Audouin; E Comperat; A Le Tourneau; S Camilleri-Broët; C Adida; T Molina; J Diebold
Journal:  Int J Surg Pathol       Date:  2003-10       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.